Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer

Zongbin Xu,Yiyi Zhang,Meifang Xu,Xin Zheng,Mengxin Lin,Jie Pan,Chengwei Ye,Yu Deng,Caiyun Jiang,Yu Lin,Xingrong Lu,Pan Chi

Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer

2019

Zongbin Xu
Yiyi Zhang
Meifang Xu
Xin Zheng
Mengxin Lin
Jie Pan
Chengwei Ye
Yu Deng
Caiyun Jiang
Yu Lin
Xingrong Lu
Pan Chi

Purpose This study aimed to evaluate the role of colony-stimulating factor 2 (CSF2) in chemotherapy resistance, prognosis, and immune response and to identify its possible mechanisms underlying drug resistance.

Keywords:

Medicine
Colorectal cancer
Demethylation
Immune system
Immunology
Cancer research
Chemotherapy
FOLFOX
Biomarker (medicine)
microRNA
Drug resistance
Cancer
DNA demethylation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations